Argatroban as an Alternative to Heparin in Extracorporeal Membrane Oxygenation Circuits
These results suggest that argatroban may be more efficacious than heparin for anticoagulation in ECMO.
World's Largest Resource for Cardiovascular Perfusion
These results suggest that argatroban may be more efficacious than heparin for anticoagulation in ECMO.
Current evidence from randomized controlled trials does not support the efficacy of most strategies to prevent AKI in the pediatric population, apart from limited evidence for dexmedetomidine and remote ischemic preconditioning.
Cardiac surgery residents can practice necessary cardiopulmonary bypass cannulation/decannulation techniques by this model.